Reagent kit for detecting epidermal growth factor acceptor third type mutant by real-time fluorescence quantitative PCR
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2008-02-27
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the field of biological technology, and is a kit for accurately and quantitatively detecting the mRNA expression of human epidermal growth factor receptor type III mutant through real-time fluorescent quantitative PCR detection technology. Background technique
[0002] Epidermal Growth Factor Receptor variant III (EGFRvIII) gene is derived from the in-frame deletion mutation at positions 276-1075 in the normal EGFR cDNA nucleotide sequence, corresponding to the 2nd to 7th outer positions of the mRNA sequence Deletion of exons. Its formation is caused by the rearrangement of the epidermal growth factor receptor (Epidermal Growth Factor Receptor, EGFR) gene amplification process, which has a certain relationship with the increase of EGFR mRNA expression. EGFRvIII can form dimers and self-phosphorylate independently of ligands such as EGF, which eventually leads to the constitutive activation of unregulated kinases, stimulates ce...